… patients about symptoms. Since then, we have supported more research using artificial intelligence to analyze … , Mark Frasier, PhD, our senior vice president of research programs explains: "Today our challenge is to … with  AMP PD  and  BRAIN Commons . Important insights into Parkinson's disease and how to treat it lie in the data …

… a mutation in the gene develop PD. Over the past few years, researchers have started to piece together Parkin’s function … part of the cell that’s responsible for converting energy into usable forms. It’s believed that Parkin can detect, and … MJFF is becoming increasingly invested in Parkin-targeted research in its own right. Just this past week, the …

… and this phase 2 phenotypic data will be shared with the PD research community on PD Online Research website. Relevance to Diagnosis/Treatment of Parkinson’s Disease:    The minimal … MJFF Research Grant … Research Staff of The Michael J. Fox Foundation …

… Objective/Rationale:  LRRK2 (Leucine-Rich Repeat Kinase 2) is a protein thought to be involved in regulating signaling pathways in cells. Mutations in the gene for LRRK2 are associated with some familial forms … Academia/Nonprofit … Research Staff of The Michael J. Fox Foundation …

… republished Todd’s essay . A Prescription for Brain Disease Research The population is aging, and so are its brains. … the fastest-growing brain disease, in the United States is nearly 1 million, with an annual economic burden of $52 … disease, and those having spent decades living with a diagnosis, as well as people with familial, genetic, and …

… that this drug will be tested in Parkinson’s patients, so researchers will be looking to find out how safe the drug is … The Foundation is currently funding a clinical study into the potential cognitive benefits of Northera … pathology,” says Jamie Eberling, PhD, associate director of research programs at MJFF. “Different processes in different …